Gene ontology annotations for TTN |
|
Experiment description of studies that identified TTN in exosomes |
1 |
Experiment ID |
494 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
CD9|CD81|CD151|CD63|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|SDCBP|TFRC|TSG101
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35931686
|
Organism |
Homo sapiens |
Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
Authors |
"Varela-EirÃÂn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃÂa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
Journal name |
Cell Death Dis
|
Publication year |
2022 |
Sample |
Chondrocytes |
Sample name |
Osteoarthritic cartilage |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
2 |
Experiment ID |
496 |
MISEV standards |
✘
|
Biophysical techniques |
✔
CD9|CD151|CD63|CD81|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|SDCBP|TFRC|TSG101
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35931686
|
Organism |
Homo sapiens |
Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
Authors |
"Varela-EirÃÂn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃÂa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
Journal name |
Cell Death Dis
|
Publication year |
2022 |
Sample |
Chondrocytes |
Sample name |
Healthy cartilage |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
3 |
Experiment ID |
497 |
MISEV standards |
✘
|
Biophysical techniques |
✔
CD9|CD151|CD63|CD81|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|RAB5A|SDCBP|TFRC|TSG101|UCHL1
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35931686
|
Organism |
Homo sapiens |
Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
Authors |
"Varela-EirÃÂn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃÂa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
Journal name |
Cell Death Dis
|
Publication year |
2022 |
Sample |
Chondrocytes |
Sample name |
T/C-28a2 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
4 |
Experiment ID |
498 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
CD9|CD151|CD63|CD81|CD82|FLOT1|FLOT2|GAPDH|LAMP1|LAMP2|RAB5A|SDCBP|TFRC|TSG101|UCHL1
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35931686
|
Organism |
Homo sapiens |
Experiment description |
Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression |
Authors |
"Varela-EirÃÂn M, Carpintero-Fernández P, Guitián-Caamaño A, Varela-Vázquez A, GarcÃÂa-Yuste A, Sánchez-Temprano A, Bravo-López SB, Yañez-Cabanas J, Fonseca E, Largo R, Mobasheri A, Caeiro JR, Mayán MD." |
Journal name |
Cell Death Dis
|
Publication year |
2022 |
Sample |
Chondrocytes |
Sample name |
T/C-28a2 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
5 |
Experiment ID |
207 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|HSP70|FLOT1
|
Enriched markers |
✔
VDAC
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23161513
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
Authors |
"Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ." |
Journal name |
Mol Cell Proteomics
|
Publication year |
2012 |
Sample |
Colorectal cancer cells |
Sample name |
DKO-1 |
Isolation/purification methods |
Differential centrifugation Filtration |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
6 |
Experiment ID |
208 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|HSP70|FLOT1
|
Enriched markers |
✔
VDAC
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23161513
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
Authors |
"Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ." |
Journal name |
Mol Cell Proteomics
|
Publication year |
2012 |
Sample |
Colorectal cancer cells |
Sample name |
Dks-8 |
Isolation/purification methods |
Differential centrifugation Filtration |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
7 |
Experiment ID |
209 |
MISEV standards |
✘
|
Biophysical techniques |
✔
TSG101|HSP70|FLOT1
|
Enriched markers |
✔
VDAC
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23161513
|
Organism |
Homo sapiens |
Experiment description |
Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. |
Authors |
"Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ." |
Journal name |
Mol Cell Proteomics
|
Publication year |
2012 |
Sample |
Colorectal cancer cells |
Sample name |
DLD-1 |
Isolation/purification methods |
Differential centrifugation Filtration |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
8 |
Experiment ID |
254 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|FLOT1|CD81
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25950383
|
Organism |
Homo sapiens |
Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
Journal name |
Pigment Cell Melanoma Res
|
Publication year |
2015 |
Sample |
Melanoma cells |
Sample name |
MNT-1 |
Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
Flotation density |
1.13 - 1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
9 |
Experiment ID |
260 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|FLOT1|CD81
|
Enriched markers |
✘
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25950383
|
Organism |
Homo sapiens |
Experiment description |
Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines |
Authors |
"Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S4, Burlet-Schiltz O1, Larue L, Muller C Nieto L" |
Journal name |
Pigment Cell Melanoma Res
|
Publication year |
2015 |
Sample |
Melanoma cells |
Sample name |
1205Lu |
Isolation/purification methods |
Differential centrifugation Unltracentrifugation Sucrose density gradient |
Flotation density |
1.13 - 1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
10 |
Experiment ID |
126 |
MISEV standards |
✘
|
Biophysical techniques |
✔
GAPDH
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry [LTQ-FT Ultra]
|
PubMed ID |
Unpublished / Not applicable
|
Organism |
Homo sapiens |
Experiment description |
Mesenchymal Stem Cell Exosomes: The Future MSC-based Therapy? |
Authors |
"Ruenn Chai Lai, Ronne Wee Yeh Yeo, Soon Sim Tan, Bin Zhang, Yijun Yin, Newman Siu Kwan Sze, Andre Choo, and Sai Kiang Lim" |
Journal name |
Mesenchymal Stem Cell Therapy
|
Publication year |
2011 |
Sample |
Mesenchymal stem cells |
Sample name |
huES9.E1 |
Isolation/purification methods |
HPLC |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Antobody array Mass spectrometry |
|
|
11 |
Experiment ID |
488 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
CD9|CD81|CD63|GAPDH|SDCBP|LAMP1|TFRC|UCHL1|FLOT2|LAMP2|FLOT1|ICAM1|RAB5B|CD151|RAB35|TSG101|RAB5A|CD82
|
Enriched markers |
✔
CANX
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
36408942
|
Organism |
Homo sapiens |
Experiment description |
Quantitative proteomic analysis of exosomes from umbilical cord mesenchymal stem cells and rat bone marrow stem cells |
Authors |
"Xu X, Yin F, Guo M, Gan G, Lin G, Wen C, Wang J, Song P, Wang J, Qi ZQ, Zhong CQ." |
Journal name |
Proteomics
|
Publication year |
2023 |
Sample |
Mesenchymal stem cells |
Sample name |
UCMSC |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectometry |
|
|
12 |
Experiment ID |
224 |
MISEV standards |
✔
EM|AFM
|
Biophysical techniques |
✔
Alix|TSG101|CD63|CD81
|
Enriched markers |
✔
GOLGA2
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25944692
|
Organism |
Homo sapiens |
Experiment description |
Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes |
Authors |
"Keerthikumar S, Gangoda L, Liem M, Fonseka P, Atukorala I, Ozcitti C, Mechler A, Adda CG, Ang CS, Mathivanan S" |
Journal name |
Oncotarget
|
Publication year |
2015 |
Sample |
Neuroblastoma cells |
Sample name |
SH-SY5Y |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation OptiPrep density gradient |
Flotation density |
1.10 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry Western blotting |
|
|
13 |
Experiment ID |
211 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|EpCAM|TFRC
|
Enriched markers |
✔
cytochrome c|GOLGA2
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23333927
|
Organism |
Homo sapiens |
Experiment description |
Characterization and proteomic analysis of ovarian cancer-derived exosomes. |
Authors |
"Liang B, Peng P, Chen S, Li L, Zhang M, Cao D, Yang J, Li H, Gui T, Li X, Shen K." |
Journal name |
J Proteomics
|
Publication year |
2013 |
Sample |
Ovarian cancer cells |
Sample name |
IGROV1 |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
Flotation density |
1.09-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
14 |
Experiment ID |
212 |
MISEV standards |
✔
CEM
|
Biophysical techniques |
✔
TSG101|Alix|EpCAM|TFRC
|
Enriched markers |
✔
Cytochrome C|GOLGA2
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
23333927
|
Organism |
Homo sapiens |
Experiment description |
Characterization and proteomic analysis of ovarian cancer-derived exosomes. |
Authors |
"Liang B, Peng P, Chen S, Li L, Zhang M, Cao D, Yang J, Li H, Gui T, Li X, Shen K." |
Journal name |
J Proteomics
|
Publication year |
2013 |
Sample |
Ovarian cancer cells |
Sample name |
OVCAR-3 |
Isolation/purification methods |
Differential centrifugation Ultracentrifugation Sucrose density gradient |
Flotation density |
1.09-1.15 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
15 |
Experiment ID |
44 |
MISEV standards |
✔
IEM
|
Biophysical techniques |
✘
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
19028452
|
Organism |
Homo sapiens |
Experiment description |
Proteomic profiling of human plasma exosomes identifies PPARgamma as an exosome-associated protein. |
Authors |
"Looze C, Yui D, Leung L, Ingham M, Kaler M, Yao X, Wu WW, Shen RF, Daniels MP, Levine SJ" |
Journal name |
BBRC
|
Publication year |
2009 |
Sample |
Plasma |
Sample name |
Plasma |
Isolation/purification methods |
Filtration Size exclusion Sucrose density gradient |
Flotation density |
1.15-1.16 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [LTQ] Western blotting Immunoelectron Microscopy |
|
|
16 |
Experiment ID |
275 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|RAB5A|CD9|CD82|CD63|CD81
|
Enriched markers |
✔
AIF
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25844599
|
Organism |
Homo sapiens |
Experiment description |
Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. |
Authors |
"Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullen A, Yachnin J, Nilsson S, Panaretakis T." |
Journal name |
Oncotarget
|
Publication year |
2015 |
Sample |
Prostate cancer cells |
Sample name |
DU145 - Docetaxel sensitive |
Isolation/purification methods |
Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.12-1.19 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry/Flow cytometry/Western blotting |
|
|
17 |
Experiment ID |
274 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
TSG101|Alix|RAB5A|CD9|CD82|CD63|CD81
|
Enriched markers |
✔
AIF
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
25844599
|
Organism |
Homo sapiens |
Experiment description |
Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. |
Authors |
"Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullen A, Yachnin J, Nilsson S, Panaretakis T." |
Journal name |
Oncotarget
|
Publication year |
2015 |
Sample |
Prostate cancer cells |
Sample name |
DU145 - Docetaxel resistant |
Isolation/purification methods |
Filtration Ultracentrifugation Sucrose density gradient |
Flotation density |
1.13-1.18 g/mL
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry Flow cytometry Western blotting |
|
|
18 |
Experiment ID |
834 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
LAMP2|CD63|FLOT1|ITGA2B|ICAM1|CD9|CD151|TFRC|RAB5A|GAPDH|AQP1|TSG101
|
Enriched markers |
✔
CANX
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35333565
|
Organism |
Homo sapiens |
Experiment description |
LAMP2A regulates the loading of proteins into exosomes |
Authors |
"Ferreira JV, da Rosa Soares A, Ramalho J, Máximo Carvalho C, Cardoso MH, Pintado P, Carvalho AS, Beck HC, Matthiesen R, Zuzarte M, Girão H, van Niel G, Pereira P" |
Journal name |
Sci Adv
|
Publication year |
2022 |
Sample |
Retinal pigment epithelial cells |
Sample name |
ARPE-19 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
19 |
Experiment ID |
835 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
CD63|FLOT1|ITGA2B|ICAM1|CD9|CD151|TFRC|RAB5A|GAPDH|AQP1|TSG101
|
Enriched markers |
✔
CANX
|
Negative markers |
✔
NTA
|
Particle analysis
|
|
Identified molecule |
Protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
35333565
|
Organism |
Homo sapiens |
Experiment description |
LAMP2A regulates the loading of proteins into exosomes |
Authors |
"Ferreira JV, da Rosa Soares A, Ramalho J, Máximo Carvalho C, Cardoso MH, Pintado P, Carvalho AS, Beck HC, Matthiesen R, Zuzarte M, Girão H, van Niel G, Pereira P" |
Journal name |
Sci Adv
|
Publication year |
2022 |
Sample |
Retinal pigment epithelial cells |
Sample name |
ARPE-19 |
Isolation/purification methods |
Differential centrifugation Filtration Ultracentrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Western blotting Mass spectrometry |
|
|
20 |
Experiment ID |
63 |
MISEV standards |
✘
|
Biophysical techniques |
✔
AQP2
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
19056867
|
Organism |
Homo sapiens |
Experiment description |
Large-scale proteomics and phosphoproteomics of urinary exosomes. |
Authors |
"Gonzales PA, Pisitkun T, Hoffert JD, Tchapyjnikov D, Star RA, Kleta R, Wang NS, Knepper MA" |
Journal name |
JASN
|
Publication year |
2009 |
Sample |
Urine |
Sample name |
Urine - Normal |
Isolation/purification methods |
Differential centrifugation |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry [LTQ] Western blotting |
|
|
21 |
Experiment ID |
196 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
Alix|TSG101|HSP70|CD9
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
22418980
|
Organism |
Homo sapiens |
Experiment description |
A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes. |
Authors |
"Raj DA, Fiume I, Capasso G, Pocsfalvi G." |
Journal name |
Kidney Int
|
Publication year |
2012 |
Sample |
Urine |
Sample name |
Urine - Normal high density |
Isolation/purification methods |
Differential centrifugation Sucrose cushion |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
22 |
Experiment ID |
197 |
MISEV standards |
✔
EM
|
Biophysical techniques |
✔
Alix|TSG101|HSP70|CD9
|
Enriched markers |
✘
|
Negative markers |
✘
|
Particle analysis
|
|
Identified molecule |
protein
|
Identification method |
Mass spectrometry
|
PubMed ID |
22418980
|
Organism |
Homo sapiens |
Experiment description |
A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes. |
Authors |
"Raj DA, Fiume I, Capasso G, Pocsfalvi G." |
Journal name |
Kidney Int
|
Publication year |
2012 |
Sample |
Urine |
Sample name |
Urine - Normal low density |
Isolation/purification methods |
Differential centrifugation Sucrose cushion |
Flotation density |
-
|
Molecules identified in the study |
Protein |
Methods used in the study |
Mass spectrometry |
|
|
Protein-protein interactions for TTN |
|
Protein Interactor |
ExoCarta ID |
Identification method |
PubMed |
Species |
1 |
UBE2H |
7328 |
Affinity Capture-MS |
|
Homo sapiens |
|
2 |
RPS12 |
6206 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
3 |
SRPK2 |
6733 |
Biochemical Activity |
|
Homo sapiens |
|
4 |
SP1 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
5 |
MYPN |
84665 |
Two-hybrid |
|
Homo sapiens |
|
6 |
RPL13A |
23521 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
7 |
ADRB2 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
8 |
ALB |
213 |
Affinity Capture-MS |
|
Homo sapiens |
|
9 |
HIST1H2BH |
8345 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
10 |
ANK1 |
286 |
Two-hybrid |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
11 |
OBSCN |
84033 |
Two-hybrid |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
12 |
TLE3 |
|
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
13 |
CHEK2 |
|
Synthetic Lethality |
|
Homo sapiens |
|
14 |
TRIM55 |
|
Two-hybrid |
|
Homo sapiens |
|
15 |
HIST1H2BL |
8340 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
16 |
SRSF2 |
6427 |
Co-fractionation |
|
Homo sapiens |
|
17 |
NEFM |
4741 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
18 |
SBDS |
51119 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
19 |
TOP2A |
7153 |
Synthetic Lethality |
|
Homo sapiens |
|
20 |
RPL10A |
4736 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
21 |
HIST1H1A |
3024 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
22 |
PGK1 |
5230 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
23 |
MLLT4 |
4301 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
24 |
RBM3 |
5935 |
Affinity Capture-MS |
|
Homo sapiens |
|
25 |
MCM2 |
4171 |
Affinity Capture-MS |
|
Homo sapiens |
|
26 |
TSC22D2 |
9819 |
Two-hybrid |
|
Homo sapiens |
|
27 |
ACTR3 |
10096 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
28 |
ANKRD2 |
|
Reconstituted Complex |
|
Homo sapiens |
|
29 |
COPS5 |
10987 |
Affinity Capture-MS |
|
Homo sapiens |
|
30 |
TRDN |
10345 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
31 |
TULP3 |
7289 |
Affinity Capture-MS |
|
Homo sapiens |
|
32 |
KMT2A |
|
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
33 |
CEP57 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
34 |
ADAM2 |
|
Affinity Capture-MS |
|
Homo sapiens |
|
35 |
MYCN |
|
Affinity Capture-MS |
|
Homo sapiens |
|
36 |
CAPN3 |
|
Two-hybrid |
|
Homo sapiens |
Two-hybrid |
|
Homo sapiens |
|
37 |
PABPC4 |
8761 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
38 |
EEF1A1 |
1915 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
39 |
DVL2 |
1856 |
Affinity Capture-MS |
|
Homo sapiens |
|
40 |
HSPA8 |
3312 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
41 |
MAPK1 |
5594 |
Biochemical Activity |
|
Homo sapiens |
Synthetic Lethality |
|
Homo sapiens |
|
42 |
PFN1 |
5216 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
43 |
CHMP4C |
92421 |
Affinity Capture-MS |
|
Homo sapiens |
|
44 |
ANXA7 |
310 |
Co-fractionation |
|
Homo sapiens |
|
45 |
HIST1H4A |
8359 |
Affinity Capture-MS |
|
Homo sapiens |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
46 |
TSPAN33 |
340348 |
Affinity Capture-MS |
|
Homo sapiens |
|
47 |
CUL4B |
8450 |
Affinity Capture-MS |
|
Homo sapiens |
|
48 |
SNAP91 |
9892 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
49 |
HIST1H2AG |
8969 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
50 |
NBR1 |
4077 |
Affinity Capture-Western |
|
Homo sapiens |
Two-hybrid |
|
Homo sapiens |
Biochemical Activity |
|
Homo sapiens |
|
51 |
TUBA1A |
7846 |
Synthetic Lethality |
|
Homo sapiens |
|
52 |
RSPH6A |
|
Affinity Capture-MS |
|
Homo sapiens |
|
53 |
ANKRD1 |
27063 |
Two-hybrid |
|
Homo sapiens |
Two-hybrid |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
54 |
PABPC1 |
26986 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
55 |
CDH1 |
999 |
Proximity Label-MS |
|
Homo sapiens |
|
56 |
TNRC18 |
|
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
57 |
RAN |
5901 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
58 |
NTRK1 |
4914 |
Affinity Capture-MS |
|
Homo sapiens |
|
59 |
HIST1H1E |
3008 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
60 |
CHEK1 |
|
Synthetic Lethality |
|
Homo sapiens |
|
61 |
DCTN1 |
1639 |
Proximity Label-MS |
|
Homo sapiens |
|
62 |
YWHAQ |
10971 |
Affinity Capture-MS |
|
Homo sapiens |
|
63 |
NFYC |
4802 |
Affinity Capture-MS |
|
Homo sapiens |
|
64 |
ENO1 |
2023 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
65 |
SMC1A |
8243 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
66 |
VAV2 |
7410 |
Two-hybrid |
|
Homo sapiens |
|
67 |
CUL2 |
8453 |
Affinity Capture-MS |
|
Homo sapiens |
|
68 |
ATP5B |
506 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
69 |
TRIM63 |
|
Two-hybrid |
|
Homo sapiens |
Two-hybrid |
|
Homo sapiens |
Two-hybrid |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
Co-crystal Structure |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
|
70 |
TCAP |
|
Two-hybrid |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
Biochemical Activity |
|
Homo sapiens |
Co-purification |
|
Homo sapiens |
Two-hybrid |
|
Homo sapiens |
Two-hybrid |
|
Homo sapiens |
Biochemical Activity |
|
Homo sapiens |
|
71 |
C3 |
718 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
72 |
ACTN1 |
87 |
Reconstituted Complex |
|
Homo sapiens |
Two-hybrid |
|
Homo sapiens |
Reconstituted Complex |
|
Homo sapiens |
Affinity Capture-Western |
|
Homo sapiens |
|
73 |
GAN |
8139 |
Affinity Capture-MS |
|
Homo sapiens |
|
74 |
HIST1H3A |
8350 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
75 |
RPL10 |
6134 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
76 |
ATP5I |
521 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
77 |
YWHAZ |
7534 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
78 |
CRYAB |
1410 |
Affinity Capture-Western |
|
Homo sapiens |
|
79 |
CUL3 |
8452 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
80 |
NR3C1 |
2908 |
Proximity Label-MS |
|
Homo sapiens |
|
81 |
PDIA3 |
2923 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
82 |
EGFR |
1956 |
Affinity Capture-MS |
|
Homo sapiens |
|
83 |
TOP3A |
|
Synthetic Lethality |
|
Homo sapiens |
|
84 |
RPS27A |
6233 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
85 |
PPIA |
5478 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
86 |
WEE1 |
7465 |
Synthetic Lethality |
|
Homo sapiens |
|
87 |
HIST1H2BO |
8348 |
Cross-Linking-MS (XL-MS) |
|
Homo sapiens |
|
88 |
LOC100132735 |
|
Protein-RNA |
|
Homo sapiens |
|
89 |
CDK2 |
1017 |
Affinity Capture-MS |
|
Homo sapiens |
Affinity Capture-MS |
|
Homo sapiens |
|
90 |
ABTB2 |
25841 |
| | | |